In Practice: Introducing mixed billing RACGP President Dr Karen Price will next week present a webinar with Dr Emil Djakic on managing the transition to mixed billing.
Renewed call to provide more support for longer consultations Respondents to a recent newsGP poll have said the change is needed to better serve Australian women.
Research links soluble paracetamol with increased risk of CVD A large study has revealed a connection between salt in soluble paracetamol with a significantly increased risk of heart attacks, stroke and death.
Boosters’ Omicron impact outlined in vaccination tool update GPs and patients can now generate personalised information on the risks and benefits associated with choosing whether or not to receive a booster shot.
Australia the first to approve Moderna vaccine in young children Kids aged 6–11 will soon be able to receive the Moderna Spikevax COVID vaccine, after it received provisional approval for use in this cohort.
Novavax rollout fast-tracked After months of delays, the rollout of Australia’s fourth COVID vaccine began over the weekend.
ATAGI releases clinical information for teen boosters Around 65% of teenagers aged 16 and over are now eligible to receive a COVID booster vaccine.
Doctors again voice opposition to pharmacy prescribing The decision to extend a UTI pharmacy prescribing pilot program has prompted a warning from the RACGP and Urological Society of Australia.
ATAGI rules on Novavax The long-awaited vaccine will be available from 21 February, but the RACGP has said general practice needs more support for the rollout.
Third COVID vaccine dose recommended for immunocompromised kids Severely immunocompromised children aged 5–11 should receive a third COVID vaccine as part of their primary course, ATAGI says.